Search results for "harm"

showing 10 items of 13866 documents

Metabolic syndrome therapy: Prevention of vascular injury by antidiabetic agents

2005

More than 65 million Americans are currently obese. Type 2 diabetes mellitus, frequently seen in obese subjects, affects 17 million adults in the United States, with a continuous and alarmingly increasing rate. To prevent development of diabetes in those who are at high risk, it is recommended to optimize meal planning and enhance physical activity to make sustained weight reduction possible. In addition to lifestyle changes, various oral antidiabetic agents are available, with diverse mechanisms of action. Some target defective insulin secretion (sulphonylureas, benzoic acid derivatives) or glucose absorption (glycosidase inhibitors), whereas others target insulin resistance (metformin, th…

medicine.medical_specialtyAdministration OralType 2 diabetes.PharmacologyInsulin resistanceInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsMetabolic SyndromeHyperplasiabusiness.industryTroglitazoneType 2 Diabetes Mellitusmedicine.diseaseMetforminTreatment OutcomeEndocrinologyBlood VesselsMetabolic syndromebusinessDiabetic AngiopathiesDyslipidemiamedicine.drugCurrent Hypertension Reports
researchProduct

Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children.

2018

Dyslipdiemia can manifest at a young age, and it is a risk factor for atherosclerotic cardiovascular disease (ASCVD), the principal cause of mortality in developed nations. Therefore, treating it a...

medicine.medical_specialtyAdolescentFamilial hypercholesterolemiastatins03 medical and health sciences0302 clinical medicineEzetimibechildrenmedicinePharmacology (medical)Risk factorIntensive care medicinePharmacologyfamilial hypercholesterolemiaAtherosclerotic cardiovascular diseasebusiness.industryfungidyslipidemiafood and beveragesGeneral Medicinemedicine.diseaseYoung age030220 oncology & carcinogenesisbusinessDeveloped country030217 neurology & neurosurgeryDyslipidemiamedicine.drugezetimibeExpert opinion on pharmacotherapy
researchProduct

Control Of Organ Transplant-Associated Graft-versus-Host Disease By Activated Host Lymphocyte Infusions

2004

Background Prolonged persistence of donor-derived T cells after organ transplantation has been proposed to improve long-term allograft survival. However, surviving transplant-derived T cells are also able to mediate devastating graft-versus-host disease (GvHD). Currently, GvHD after organ transplantation is usually refractory to conventional therapy and the disease outcome fatal. Methods Graft-reactive host T cells were generated ex vivo from a patient suffering from a severe and refractory liver-transplant-associated GvHD. To control GvHD, activated alloreactive host T cells were repetitively retransferred into the patient (activated host lymphocyte infusion [aHLI]). Results Adoptive trans…

medicine.medical_specialtyAdoptive cell transferLymphocytemedicine.medical_treatmentGraft vs Host Diseasechemical and pharmacologic phenomenaLymphocyte ActivationImmunotherapy AdoptiveSeverity of Illness IndexOrgan transplantationBlood Transfusion AutologousmedicineHumansAgedTransplantationbusiness.industryImmunotherapymedicine.diseaseAdoptive TransferLiver TransplantationTransplantationsurgical procedures operativeGraft-versus-host diseasemedicine.anatomical_structureLymphocyte TransfusionImmunologyFemaleStem cellEpidermolysis BullosabusinessEx vivoTransplantation
researchProduct

Adrenergic modulation of astroglial phospholipase D activity and cell proliferation.

1999

As phospholipase D (PLD) activation has been associated with mitogenic signalling in several cell types, we tested an association between adrenergic activation of PLD and cellular proliferation in primary cultures of rat cortical astrocytes. In 2-week old cultures, PLD activation by noradrenaline (EC50: 0.49 microM) was inhibited by prazosin, a specific antagonist at alpha1-adrenergic receptors (IC50: 0.23 microM). Adrenergic PLD activation was not affected by genistein, an inhibitor of tyrosine kinases, or by Ro 31-8220, an inhibitor of protein kinase C (PKC), but was dose-dependently depressed in the presence of brefeldin A (1-100 microg/ml), an inhibitor of ARF activation. In experiments…

medicine.medical_specialtyAdrenergic AntagonistsAdrenergicBiologyPharmacologychemistry.chemical_compoundNorepinephrineGTP-Binding ProteinsIsoprenalineInternal medicinemedicineAdrenergic antagonistPrazosinPhospholipase DPhospholipase D activityAnimalsMolecular BiologyProtein kinase CCells CulturedBrefeldin APhospholipase DGeneral NeurosciencePrazosinBrefeldin AAdrenergic AgonistsPropranololRatsReceptors AdrenergicEndocrinologychemistryAlcoholsAstrocyteslipids (amino acids peptides and proteins)Neurology (clinical)Cell DivisionDevelopmental Biologymedicine.drugSignal TransductionBrain research
researchProduct

Beta-adrenoceptor-mediated facilitation of endogenous noradrenaline release from rat isolated trachea.

1994

Overflow of endogenous noradrenaline from rat isolated trachea was evoked by electrical field stimulation (3 Hz, 540 pulses) in the presence of yohimbine, desipramine and tyrosine. Isoprenaline 100 nmol/l increased the evoked overflow of noradrenaline by about 65%. This effect was antagonized by propranolol (100 nmol/l) and the beta 2-selective adrenoceptor antagonist ICI 118,551 (100 nmol/l), but not by the beta 1-selective adrenoceptor antagonist CGP 20712 A (100 nmol/l). The beta 2-selective adrenoceptor agonist formoterol (1-100 nmol/l) also facilitated the evoked overflow of noradrenaline, but maximally by only about 25% at 10 nmol/l, i.e. formoterol behaved as a partial agonist at the…

medicine.medical_specialtyAdrenergic beta-AntagonistsIndomethacinAdrenergicPropranololIn Vitro TechniquesPartial agonistNorepinephrine (medication)Rats Sprague-DawleyNorepinephrineAdrenergic AgentsIsoprenalineInternal medicineReceptors Adrenergic betamedicineAnimalsPharmacologyChemistryAntagonistGeneral MedicineElectric StimulationYohimbineRatsTracheaEndocrinologycardiovascular systemFemaleFormoterolmedicine.drugSignal TransductionNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Management of Blood Pressure and Heart Rate in Patients with Acute Stroke

2017

BACKGROUND: Stroke represent one of the most devastating of all neurological diseases, affecting about 15 million people per year and is an important cause of morbidity and mortality worldwide and currently the leading cause of adult disability in developed countries. Blood pressure and heart rate may undergo several modifications in patients with both ischemic and hemorrhagic stroke in fact raised blood pressure levels may lead to cerebral edema, hematoma expansion or hemorrhagic transformation and in contrast low blood pressure can lead to increased cerebral infarction or perihematomal ischemia. In addition, ECG abnormalities and cardiac arrhythmias, especially atrial fibrillation, are re…

medicine.medical_specialtyAdrenergic beta-AntagonistsIschemiaInfarctionBlood Pressureheart rate monitoringSudden death03 medical and health sciences0302 clinical medicineHeart RateInternal medicineDrug DiscoverymedicineHumansAcute strokehemorrhagic strokecardiovascular diseasesDiureticsStrokePharmacologyCerebral infarctionbusiness.industrymiocardial infarctionAtrial fibrillationmedicine.diseaseStrokeblood pressure modulationBlood pressure030220 oncology & carcinogenesisHeart failureAcute Diseaseperihematomal ischemiaCardiologybusiness030217 neurology & neurosurgeryCurrent Pharmaceutical Design
researchProduct

Effect of aging on pain relief in the older cancer patients: pharmacokinetic and pharmacodynamic aspects.

2016

The prevalence of cancer rises with advancing age. A large number of cancer patients are aged over 65 years, and it is expected that even more patients will develop cancer as a consequence of the g...

medicine.medical_specialtyAgingPain reliefPainToxicology03 medical and health sciences0302 clinical medicinePharmacokineticsInternal medicineNeoplasmsMedicineAnimalsHumans030212 general & internal medicineAgedPharmacologyAnalgesicsbusiness.industryCancerGeneral Medicinemedicine.diseaseToxicology; Pharmacology030220 oncology & carcinogenesisAnesthesiabusinessPharmacodynamic aspectsExpert opinion on drug metabolismtoxicology
researchProduct

Depression in the nursing home: a cluster-randomized stepped-wedge study to probe the effectiveness of a novel case management approach to improve tr…

2019

Abstract Background Depression is the second most common psychiatric illness in old people. Up to 30% of nursing home residents suffer from minor or major depression. Although depressive disorders in old age can be improved and even cured with adequate therapy, they often go unnoticed in nursing home residents and remain untreated. This highlights a striking deficit in health care and might results not only in lower quality of life among those concerned but also in poor physical functioning, premature mortality and increased hospitalization rates. Methods The aim of the interdisciplinary research project DAVOS is to implement an innovative and stepped structural case management program to i…

medicine.medical_specialtyAgingTime FactorsMedicine (miscellaneous)Late-life depressionCase management03 medical and health sciencesStudy Protocol0302 clinical medicineQuality of life (healthcare)Informed consentIntervention (counseling)GermanyHealth caremedicinePrevalenceDementiaHomes for the AgedHumansMulticenter Studies as TopicPharmacology (medical)Stepped-wedge design030212 general & internal medicinePsychotherapeutic treatmentDepression (differential diagnoses)Cluster-randomized intervention studyRandomized Controlled Trials as Topiclcsh:R5-920business.industryDepressionNursing homeAge FactorsLate life depressionmedicine.diseaseNursing HomesTreatment OutcomeFamily medicineCohortbusinesslcsh:Medicine (General)030217 neurology & neurosurgeryTrials
researchProduct

9.11 Association between Plasma Aldosterone, Metabolic Syndrome and Left Ventricular Mass in Essential Hypertension

2008

medicine.medical_specialtyAldosteronebusiness.industrymedicine.diseaseEssential hypertensionLeft ventricular masschemistry.chemical_compoundPharmacotherapychemistryInternal medicineInternal MedicineCardiologymedicineMetabolic syndromeCardiology and Cardiovascular MedicinebusinessHigh Blood Pressure & Cardiovascular Prevention
researchProduct

Conceptos nuevos sobre el sistema renina angiotensina

2010

In recent years, new components of the renin-angiotensin system have been described. Five new polypeptides with their synthesis routes and the enzymes involved in their synthesis have been identified. Receptors for angiotensin 1–7, angiotensin IV and renin have also been described. The knowledge of local renin-angiotensin systems has been extended with the discovery of the intracellular systems. Mutations and polymorphisms in the genes of the different components of the renin-angiotensin system have been described. These could be involved in the development of hypertension and cardiovascular disease. In addition, aliskiren, the first component of the new group of renin direct inhibitors, ha…

medicine.medical_specialtyAliskirenBiologyPharmacologyAngiotensin IVchemistry.chemical_compoundEndocrinologychemistryInternal medicineRenin–angiotensin systemInternal MedicinemedicineCardiology and Cardiovascular MedicineReceptorHipertensión y Riesgo Vascular
researchProduct